EIDO and C2-Ai announce strategic technology partnership
Posted:
EIDO and C2-Ai are delighted to announce a strategic technology partnership, bringing digital informed consent and big data into partnership for the benefit of clinicians and patients.
EIDO Healthcare has been providing its informed consent tools to hospitals for over 20 years, to support patients in making informed, joint decisions about their treatment.
In use by over 65% of acute NHS hospitals and 85% of acute private hospitals, across five continents and in use in over 1000 hospitals, EIDO’s solutions enhance patient experience, improve clinical workflow and protect organisational and clinical reputations.
Map My Mole, by Community Dermatology Limited, is a service that offers remote assessments of moles and skin lesions by consultant dermatologists.
Their missions in to bring skin checks to where the patient is, whether at home or in one…
Working in collaboration with partners across health and care, its multi-disciplinary team carries out health technology assessments of health or care technologies that are not a medicine and publishes national guidance on their use in Wales.
Read more here.